Artificial intelligence is moving deeper into medical imaging, shifting from standalone diagnostic software toward AI capabilities embedded directly in scanners and clinical workflows. A new market analysis from ResearchAndMarkets.com projects the global AI-enabled imaging modalities market will grow from $3.41 billion in 2025 to $17.84 billion by 2036, as hospitals increasingly use AI to improve image reconstruction, detection, workflow automation and diagnostic efficiency.

Medical imaging is becoming an increasingly computational business.

CT, MRI, X-ray and ultrasound systems are no longer defined solely by their sensors, scanners and image quality. Increasingly, software and artificial intelligence determine how images are acquired, reconstructed, enhanced and interpreted.

That shift is creating a rapidly expanding market for AI-enabled imaging modalities, according to a new market report from ResearchAndMarkets.com.

The report estimates that the global market was worth $3.41 billion in 2025 and forecasts it will reach $17.84 billion by 2036, representing a 16.24% compound annual growth rate from 2026 through 2036.

The growth reflects a broader transformation in healthcare AI: intelligence is moving closer to the point where clinical data is generated.

Rather than treating AI as an application that sits separately from imaging equipment, manufacturers are increasingly integrating algorithms into scanners and imaging platforms themselves. These systems can assist with image acquisition, reconstruction, enhancement, segmentation, detection, quantification and workflow prioritization.

For radiology departments dealing with growing imaging volumes and limited specialist capacity, that integration could be consequential.

AI-assisted reconstruction, for example, can help produce usable images from lower-dose or faster scans. Automated segmentation can identify anatomical structures without requiring clinicians to manually outline them. Detection algorithms can flag potentially significant findings, while workflow systems can help prioritize cases that may require faster attention.

The result is an imaging environment in which AI becomes part of the underlying workflow rather than an optional analytical layer.

From AI software to intelligent scanners

The market’s evolution is particularly visible in the strategies of major medical-imaging manufacturers.

GE HealthCare, Siemens Healthineers, Philips, Canon, FUJIFILM and Samsung Healthcare are among the companies developing imaging technologies that increasingly combine hardware, AI software and healthcare IT.

That integration is important because clinical AI does not operate in isolation.

An algorithm can identify an abnormality, but its usefulness depends on whether it can access the right image data, fit into the radiologist’s workflow and communicate results through systems such as PACS, RIS and electronic medical records.

This is pushing the industry toward integrated imaging ecosystems.

Modern AI-enabled modalities can incorporate intelligent protocol selection, automated image optimization and AI-assisted reconstruction directly into the scanning process. The technology can also connect imaging outputs with downstream clinical workflows.

That architecture potentially addresses one of healthcare AI’s biggest problems: the difference between demonstrating that an algorithm works and making it useful in routine clinical practice.

Why imaging is becoming an AI infrastructure market

Radiology departments generate enormous volumes of structured and unstructured data. As imaging workloads increase, hospitals face pressure to process those studies efficiently while maintaining diagnostic quality.

AI can help automate repetitive tasks, but the technology’s impact increasingly depends on infrastructure.

Healthcare organizations need sufficient compute capacity, data connectivity, interoperability and governance to deploy AI at scale. They also need systems capable of operating consistently across different scanners, clinical environments and patient populations.

This is turning AI-enabled imaging into an enterprise infrastructure decision, rather than simply a software purchase.

For hospitals, upgrading to AI-enabled CT or MRI may affect radiology workflows, IT architecture, cybersecurity, staff training, procurement and regulatory compliance.

The economics are equally important.

Healthcare providers are under pressure to increase patient throughput while controlling costs. An imaging system that can reduce scan times, improve reconstruction efficiency or automate portions of workflow could create value beyond diagnostic performance alone.

But those benefits must be demonstrated in real clinical environments.

Regulation remains a major hurdle

The market’s growth does not eliminate the challenges surrounding medical AI.

Healthcare organizations must consider regulatory approval, clinical validation, model reliability, cybersecurity and interoperability. AI systems that perform well in controlled evaluations can encounter different patient populations, imaging protocols and operating conditions in real hospitals.

There is also a distinction between AI that improves the technical quality of an image and AI that influences clinical decision-making.

The closer an AI system moves toward diagnosis or treatment recommendations, the greater the need for clinical evidence, appropriate oversight and regulatory controls.

That makes integration with existing medical workflows particularly important.

The industry is consequently moving away from the idea that AI success can be measured simply by model accuracy. Hospitals increasingly need to evaluate whether AI improves the entire workflow without introducing unacceptable risks or operational complexity.

GE HealthCare, Siemens and Philips face a changing competitive landscape

The established imaging companies have an advantage because they control both the hardware and much of the clinical workflow surrounding it.

GE HealthCare, Siemens Healthineers, Philips and Canon Medical can integrate AI into scanner architectures, while specialist AI companies can focus on specific clinical applications.

The competitive landscape could therefore evolve along two paths.

One is the development of increasingly intelligent imaging hardware. The other is an ecosystem model in which manufacturers, healthcare providers and AI developers connect specialized algorithms to imaging platforms.

Interoperability will determine how much choice hospitals retain.

Healthcare providers generally do not want AI investments that lock them into a single vendor’s technology stack. Open interfaces and compatibility with PACS, RIS and EMR systems can therefore become strategic differentiators.

The enterprise adoption question

For CIOs, CMIOs and radiology leaders, the most important question is unlikely to be whether AI can improve imaging.

The question will be where AI produces measurable operational or clinical value.

Hospitals evaluating AI-enabled modalities will need to consider factors including acquisition cost, workflow integration, regulatory status, infrastructure requirements and evidence of clinical benefit.

They will also need to examine whether AI capabilities can be updated as models and clinical requirements evolve.

That could make software architecture almost as important as scanner specifications.

The projected expansion of the AI-enabled imaging modalities market suggests that the industry is entering a new phase. AI is becoming embedded in the equipment used to generate medical images, the software used to process them and the workflows used to interpret them.

If that trajectory continues, the next generation of radiology infrastructure may be defined less by the scanner alone and more by the combination of imaging hardware, AI compute, clinical software and connected healthcare data.

Market Landscape

The AI-enabled imaging market sits at the intersection of medical devices, healthcare AI, cloud computing and clinical IT.

The strongest growth opportunities are likely to emerge where AI can produce measurable improvements in imaging throughput, image quality or workflow efficiency. CT, MRI, X-ray and ultrasound all offer different opportunities for AI-assisted reconstruction, detection and automation.

The competitive landscape includes established imaging OEMs such as GE HealthCare, Siemens Healthineers, Philips and Canon, alongside specialist AI developers and healthcare technology companies.

For healthcare enterprises, interoperability may become a defining purchasing criterion. AI-enabled scanners that integrate cleanly with PACS, RIS and EMR infrastructure can reduce deployment friction, while proprietary architectures may increase long-term switching costs.

The market also reflects a larger healthcare AI trend: moving AI from pilot projects into production environments. That requires not only validated models, but reliable infrastructure, governance, cybersecurity and clinical workflow integration.

Top Insights

• AI-enabled imaging is becoming an infrastructure market, with CT, MRI, X-ray and ultrasound systems increasingly integrating AI directly into acquisition and clinical workflows.
• ResearchAndMarkets.com forecasts 16.24% CAGR through 2036, reflecting growing demand for faster diagnostics, automated workflows and higher imaging throughput.
• GE HealthCare, Siemens Healthineers, Philips and Canon face growing AI competition, as specialist software companies expand into medical imaging workflows.
• Hospitals must evaluate more than algorithm accuracy, including interoperability, regulatory approval, cybersecurity, infrastructure costs and measurable clinical or operational outcomes.
• Embedded AI could reshape radiology infrastructure, connecting scanners, PACS, RIS, EMR systems and intelligent image-processing capabilities into integrated enterprise platforms.

Power Tomorrow’s Intelligence — Build It with TechEdgeAI